2002). Additionally, a significant number of diastolic heart failure patients may progress to systolic heart failure (Cahill et al. 2006). Fbln5−/−mice offer a model of diastolic dysfunction for investigating heart failure progression and possible pharmaceutical treatments. This evidence concerns the gene FBLN5 and systolic heart failure.